These studies have demonstrated the important role for miRA-27a and its target gene ZBTB10 in regulating tumor growth, metastasis and chemotherapy resistance, which suggests that miR-27a might be a clinically useful marker for selecting high-risk cancer patients with distant metastasis. The gene discussed is ZBTB10; the disease is cancer.